Asset pricing underestimates physical climate risks, warns DWS

The EUR 700 billion asset manager now incorporates physical climate risk in portfolio construction, so favoring firms with a more climate change-resilient business model. Globally, weather events have already hit share prices on several occasions and new data suggest markets have not yet priced in this risk.

In autumn 2017, Hurricane Maria ravaged Puerto Rico, one of the world's leading pharmaceutical manufactures. The hurricane devastated production facilities of companies such as Eli Lilly and AstraZeneca. | Photo: AP Photo/Gerald Herbert

The Caribbean island of Puerto Rico is host to manufacturing plants belonging to some of the world's largest pharmaceutical companies, including US giant Johnson & Johnson, Switzerland's Novartis and the UK and Swedish firm AstraZeneca.

Despite Puerto Rico's population of just 3.3 million, the US Food and Drug Administration (FDA) spends USD 40 billion (EUR 34 billion) annually on drugs produced on the island.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

Further reading

Latest news


Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch